A fully human IgG1 anti-PD-L1 MAb in an in vitro assay enhances antigen-specific T-cell responses

समान संसाधन

• Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells
  द्वारा: Lepone, Lauren, और अन्य
  प्रकाशित: (2015)
• Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression
  द्वारा: Grenga, Italia, और अन्य
  प्रकाशित: (2015)
• Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody
  द्वारा: Donahue, Renee N., और अन्य
  प्रकाशित: (2017)
• PD-L1 and MHC-I expression in 19 human tumor cell lines and modulation by interferon-gamma treatment
  द्वारा: Grenga, Italia, और अन्य
  प्रकाशित: (2014)
• PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients
  द्वारा: Lepone, Lauren, और अन्य
  प्रकाशित: (2014)